EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Differentiation of stem-like CD4 + T cells modulates early effector responses in colorectal cancer

Yu Zhang, Hu Nie, Zixuan Dai, Liying Zhao, Yihong Wan, Yi Wang, Yikang Chen, Xinhua Chen, Zhijun Xu, Jixing Zhong, Dechun Cheng, Qiushuang Wu, Cong Ouyang, Peilu Lin, Haijun Deng, Zhen Liu, Guoxin Li, Chengqian Yin, Lei Zhang

Science · 2026-11-12 · 394 (6825)

DOI: 10.1126/science.ady7788 ↗
AbstractBibliografische Angaben

Abstract

Strategies to improve cancer immunotherapy have largely focused on the intratumor immunosuppressive microenvironment, whereas approaches to amplify peripheral T cells and promote tumor recruitment have not been thoroughly explored. Using imaging mass cytometry in patients with colorectal cancer (CRC), we observed T helper 1 (T H 1)–like immune architectures in mismatch repair–deficient tumors associated with response to anti–programmed cell death protein 1 (PD-1) immunotherapy. By contrast, mismatch repair–proficient (pMMR) tumors showed regulatory T–dominant spatial interactions. Clonal analyses revealed that stem-like CD4 + T cells differentiated into T H 1-like cells after PD-1 blockade. In pMMR CRC mouse models, combined OX40 agonist and PD-1 blockade suppressed tumor progression by expanding Il7r + early effector CD4 + intermediates in tumor-draining lymph nodes, promoting migration and connection with T H 1-like cells. This was accompanied by interferon-γ–dependent induction of immunostimulatory monocyte-macrophages and CD8 + effector T cells. These findings suggest that leveraging peripheral CD4 + T cell amplification may improve immunotherapy responses.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →